MDM2 (BSB-64)
MDM2 (BSB-64)
| Application | IHC |
| Clone | BSB-64 |
| Conjugué | Unconjugated |
| Conseil | |
| Couleur | |
| Hôte | |
| Immunogène | |
| Isotype | |
| Localisation | Nuclear |
| Pathologie | Sarcoma, Soft Tissues, Breast Cancer |
| Predicted reactivity | |
| Purification | |
| Réactivité | |
| Spécificité | |
| Taille | |
| Tissus controles | Testis, Tonsil, Cervix, Placenta, LipoSarcoma, Soft Tissue, Testicular Cancer |
Prêt à l'emploi
| Conditionnement | Reference | Supplier | Certification | Dilution | TDS | Quantity |
|---|---|---|---|---|---|---|
| 3 ml | BSB2978 |
|
IVD/CE | RTU |
|
|
| 7 ml | BSB2979 |
|
IVD/CE | RTU |
|
|
| 15 ml | BSB2980 |
|
IVD/CE | RTU |
|